UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Microsoft
MSFT
|
+$919M |
| 2 |
Snowflake
SNOW
|
+$576M |
| 3 |
Sea Limited
SE
|
+$521M |
| 4 |
Procter & Gamble
PG
|
+$485M |
| 5 |
Snap
SNAP
|
+$412M |
Top Sells
| 1 |
Infosys
INFY
|
+$428M |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$350M |
| 3 |
Lowe's Companies
LOW
|
+$219M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$183M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$183M |
Sector Composition
| 1 | Technology | 26.21% |
| 2 | Healthcare | 13.25% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 12.29% |
| 5 | Communication Services | 10.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Graham Holdings Company
GHC
$5.13B
| $2.86M | ﹤0.01% |
4,858
+450
| +10% | +$265K |
|
1627
Pacira BioSciences
PCRX
$1.21B
| $2.85M | ﹤0.01% |
50,891
| – | – |
|
1628
Arcosa
ACA
$4.81B
| $2.84M | ﹤0.01% |
56,678
| – | – |
|
1629
Worthington Enterprises
WOR
$3.26B
| $2.83M | ﹤0.01% |
87,239
| – | – |
|
1630
Plexus
PLXS
$3.8B
| $2.83M | ﹤0.01% |
31,655
+210
| +0.7% | +$18.8K |
|
1631
Pediatrix Medical
MD
$1.48B
| $2.83M | ﹤0.01% |
99,552
+28,701
| +41% | +$816K |
|
1632
Certara
CERT
$1.75B
| $2.8M | ﹤0.01% |
84,565
+36,496
| +76% | +$1.21M |
|
1633
CryoPort
CYRX
$474M
| $2.8M | ﹤0.01% |
42,065
+2,064
| +5% | +$137K |
|
1634
Stepan Co
SCL
$1.12B
| $2.8M | ﹤0.01% |
24,761
+259
| +1% | +$29.3K |
|
1635
Calix
CALX
$4.13B
| $2.79M | ﹤0.01% |
56,503
-1,138
| -2% | -$56.3K |
|
1636
FormFactor
FORM
$2.36B
| $2.79M | ﹤0.01% |
74,761
+996
| +1% | +$37.2K |
|
1637
Editas Medicine
EDIT
$244M
| $2.78M | ﹤0.01% |
67,633
+3,050
| +5% | +$125K |
|
1638
Vir Biotechnology
VIR
$727M
| $2.77M | ﹤0.01% |
63,719
+549
| +0.9% | +$23.9K |
|
1639
Plains GP Holdings
PAGP
$3.69B
| $2.77M | ﹤0.01% |
257,266
+987
| +0.4% | +$10.6K |
|
|
AVYA
1640
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $2.76M | ﹤0.01% |
139,350
+22,867
| +20% | +$453K |
|
1641
First Merchants
FRME
$2.33B
| $2.75M | ﹤0.01% |
65,830
| – | – |
|
|
MFA
1642
MFA Financial
MFA
$1.05B
| $2.74M | ﹤0.01% |
150,130
+14,006
| +10% | +$256K |
|
1643
Boot Barn
BOOT
$5.76B
| $2.74M | ﹤0.01% |
30,858
+3,055
| +11% | +$271K |
|
1644
Vroom, Inc. Common Stock
VRM
$137M
| $2.73M | ﹤0.01% |
1,547
+188
| +14% | +$332K |
|
1645
Urban Outfitters
URBN
$6.43B
| $2.73M | ﹤0.01% |
91,902
-6,717
| -7% | -$199K |
|
1646
Amicus Therapeutics
FOLD
$2.47B
| $2.73M | ﹤0.01% |
285,641
-39,196
| -12% | -$374K |
|
1647
B&G Foods
BGS
$369M
| $2.73M | ﹤0.01% |
91,212
+4,270
| +5% | +$128K |
|
|
ESMT
1648
DELISTED
EngageSmart, Inc.
ESMT
| $2.72M | ﹤0.01% |
+80,000
| New | +$2.72M |
|
|
UHT
1649
Universal Health Realty Income Trust
UHT
$583M
| $2.72M | ﹤0.01% |
49,295
+649
| +1% | +$35.9K |
|
1650
Liberty Latin America Class C
LILAK
$1.55B
| $2.72M | ﹤0.01% |
207,439
-5,967
| -3% | -$78.3K |
|